Optimisation of the 10-23 DNAzyme-substrate pairing interactions enhanced RNA cleavage activity at purine-cytosine target sites.

The 10-23 RNA cleaving DNAzyme has been shown to cleave any purine-pyrimidine (RY) junction under simulated physiological conditions. In this study, we systematically examine the DNAzymes relative activity against different RY combinations in order to determine the hierarchy of substrate core dinucleotide sequence susceptibility. The reactivity of each substrate dinucleotide compared in the same background sequence with the appropriately matched DNAzyme was found to follow the scheme AU = GU >> or = GC >> AC. The relatively poor activity of the DNAzyme against AC and GC containing substrates was found to be improved substantially by modifications to the binding domain which subtly weaken its interaction with the substrate core. The most effective modification resulting in rate enhancement of up to 200-fold, was achieved by substitution of deoxyguanine with deoxyinosine such that the base pair interaction with the RNA substrates core C is reduced from three hydrogen bonds to two. The increased cleavage activity generated by this modification could be important for application of the 10-23 DNAzyme particularly when the target site core is an AC dinucleotide.

[1]  M. Cairns,et al.  Nucleic acid mutation analysis using catalytic DNA. , 2000, Nucleic acids research.

[2]  M. Cairns,et al.  Catalytic nucleic acids: from lab to applications. , 2000, Pharmacological reviews.

[3]  B. Sproat,et al.  Extending the cleavage rules for the hammerhead ribozyme: mutating adenosine15.1 to inosine15.1 changes the cleavage site specificity from N16.2U16.1H17 to N16.2C16.1H17. , 1998, Nucleic Acids Research.

[4]  M. Waring,et al.  The use of diaminopurine to investigate structural properties of nucleic acids and molecular recognition between ligands and DNA. , 1998, Nucleic acids research.

[5]  M. Cairns,et al.  Suppression of Smooth Muscle Cell Proliferation by a c-myc RNA-cleaving Deoxyribozyme* , 1999, The Journal of Biological Chemistry.

[6]  G. F. Joyce,et al.  Mechanism and utility of an RNA-cleaving DNA enzyme. , 1998, Biochemistry.

[7]  M. Cairns,et al.  The influence of arm length asymmetry and base substitution on the activity of the 10-23 DNA enzyme. , 2000, Antisense & nucleic acid drug development.

[8]  O. Uhlenbeck,et al.  The effect of base mismatches in the substrate recognition helices of hammerhead ribozymes on binding and catalysis. , 1995, Nucleic acids research.

[9]  P. Hendry,et al.  Unexpected anisotropy in substrate cleavage rates by asymmetric hammerhead ribozymes. , 1996, Nucleic acids research.

[10]  M. Cairns,et al.  Target site selection for an RNA-cleaving catalytic DNA , 1999, Nature Biotechnology.

[11]  O. Uhlenbeck,et al.  Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. , 1987, Nucleic acids research.

[12]  R. Tritz,et al.  RNA catalytic properties of the minimum (-)sTRSV sequence. , 1989, Biochemistry.

[13]  G. F. Joyce,et al.  A general purpose RNA-cleaving DNA enzyme. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[14]  N. Sugimoto,et al.  Thermodynamic parameters to predict stability of RNA/DNA hybrid duplexes. , 1995, Biochemistry.

[15]  L. Khachigian,et al.  New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury , 1999, Nature Medicine.

[16]  W. Gerlach,et al.  Simple RNA enzymes with new and highly specific endoribonuclease activities , 1988, Nature.